001440951 000__ 05230cam\a2200565\i\4500
001440951 001__ 1440951
001440951 003__ OCoLC
001440951 005__ 20230309004711.0
001440951 006__ m\\\\\o\\d\\\\\\\\
001440951 007__ cr\un\nnnunnun
001440951 008__ 211117s2021\\\\si\\\\\\o\\\\\000\0\eng\d
001440951 019__ $$a1285560813$$a1285568440$$a1292517693$$a1294353031
001440951 020__ $$a9789811635298$$q(electronic bk.)
001440951 020__ $$a9811635293$$q(electronic bk.)
001440951 020__ $$z9811635285
001440951 020__ $$z9789811635281
001440951 0247_ $$a10.1007/978-981-16-3529-8$$2doi
001440951 035__ $$aSP(OCoLC)1285491557
001440951 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dORU$$dEBLCP$$dOCLCF$$dDKU$$dOCLCO$$dDCT$$dSFB$$dOCLCO$$dOCLCQ$$dOCLCO$$dUKAHL$$dOCLCQ
001440951 049__ $$aISEA
001440951 050_4 $$aTP248.27.P55
001440951 08204 $$a615.3/21$$223
001440951 24500 $$aBiotechnology of anti-diabetic medicinal plants /$$cSaikat Gantait, Sandeep Kumar Verma, Amit Baran Sharangi, editors.
001440951 264_1 $$aSingapore :$$bSpringer,$$c2021.
001440951 300__ $$a1 online resource
001440951 336__ $$atext$$btxt$$2rdacontent
001440951 337__ $$acomputer$$bc$$2rdamedia
001440951 338__ $$aonline resource$$bcr$$2rdacarrier
001440951 347__ $$atext file
001440951 347__ $$bPDF
001440951 5050_ $$a1 In vitro approach and quantification of uerarin and genistein -- Valuable antidiabetic compounds from Pueraria tuberosa -- 2 In Vitro Exploitation of Medicinal Plants for Continuous Supply of Antidiabetic Bioactive Compounds -- 3 Lower plants as potential source of antidiabetic compounds: The present knowledge and future prospects -- 4 Tissue culture mediated biotechnological intervention in Centella asiatica: A potential antidiabetic plant -- 5 In Vitro Approaches for Mass-Propagation of Stevia rebaudiana -- 6 Swertia chirayita, an endangered anti-diabetic plant: trends in biotechnological interventions -- 7 In vitro propagation and biotechnological improvement strategies of plants with high-intensity sweetener and anti-diabetic activities -- 8 In Vitro Culture Techniques and Metabolite Engineering for Enhanced Anti-Diabetic Secondary Metabolite Production -- 9 Saffron: A prized herb with therapeutic potential against diabetes -- 10 New Insights to Enhance the Desired Anti-Diabetic Compounds in Medicinal and Aromatic Plants Exposed to Abiotic Stress Factors -- 11 Boosting of bioactive secondary metabolites in antidiabetic plants through elicitation: A simple technology for better future -- 12 Rhizobium rhizogenes mediated genetic transformation of antidiabetic plants -- 13 Production of anti-diabetic lignans in flax cell cultures -- 14 Artificial seed development of selected anti-diabetic plants, their storage and regeneration: Progress and prospect -- 15 Cryopreservation of Anti-diabetic plants.
001440951 506__ $$aAccess limited to authorized users.
001440951 520__ $$aThis book is a unique overview of insights on the genetic basis of anti-diabetic activity, chemistry, physiology, biotechnology, mode-of-action, as well as cellular mechanisms of anti-diabetic secondary metabolites from medicinal plants. The World Health Organization estimated that 80% of the populations of developing countries rely on traditional medicines, mostly plant drugs, for their primary health care needs. There is an increasing demand for medicinal plants having anti-diabetic potential in both developing and developed countries. The expanding trade in medicinal plants has serious implications on the survival of several plant species, with many under threat to become extinct. This book describes various approaches to conserve these genetic resources. It discusses the whole spectrum of biotechnological tools from micro-propagation for large-scale multiplication, cell-culture techniques to the biosynthesis and enhancement of pharmaceutical compounds in the plants. It also discusses the genetic transformation as well as short- to long-term conservation of plant genetic resources via synthetic seed production and cryopreservation, respectively. The book is enriched with expert contributions from across the globe. This reference book is useful for researchers in the pharmaceutical and biotechnological industries, medicinal chemists, biochemists, botanists, molecular biologists, academicians, students as well as diabetic patients, traditional medicine practitioners, scientists in medicinal and aromatic plants, Ayurveda, Siddha, Unani and other traditional medical practitioners.
001440951 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed November 19, 2021).
001440951 650_0 $$aMedicinal plants$$xBiotechnology.
001440951 650_0 $$aMateria medica, Vegetable.
001440951 650_0 $$aDiabetes$$xAlternative treatment.
001440951 650_6 $$aPlantes médicinales$$xBiotechnologie.
001440951 650_6 $$aPhytothérapie.
001440951 655_0 $$aElectronic books.
001440951 7001_ $$aGantait, Saikat,$$eeditor.
001440951 7001_ $$aVerma, Sandeep Kumar,$$eeditor.
001440951 7001_ $$aSharangi, A. B.$$q(Amit Baran),$$eeditor.
001440951 77608 $$iPrint version:$$tBiotechnology of anti-diabetic medicinal plants.$$dSingapore : Springer, 2021$$z9811635285$$z9789811635281$$w(OCoLC)1252413937
001440951 852__ $$bebk
001440951 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-16-3529-8$$zOnline Access$$91397441.1
001440951 909CO $$ooai:library.usi.edu:1440951$$pGLOBAL_SET
001440951 980__ $$aBIB
001440951 980__ $$aEBOOK
001440951 982__ $$aEbook
001440951 983__ $$aOnline
001440951 994__ $$a92$$bISE